Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z011601 | OT |
Symptoms were not reported/ No additional AE; TE. Vaccines were administered to patients.; This Spontaneous report was received from a Certified Medical Assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 06-Feb-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) lyophilisate and solvent for solution for injection, Lot Number: Z011601, Expiration date: 11-Jul-2027 (Dose, route and anatomical site not reported). The avccine was reconstituted with a sterile diluent (lot# and expiration date not reported) for prophylaxis. The vaccine had a temperature excursion of -14°C up to -10°C (-13.6 C) during a time frame for 2 hours 5 minutes 0 seconds. There was no previous temperature excursion. Symptoms were not reported. No additional adverse evento (AE). Linked Case(s): Same Reporter: US-009507513-2384666, Same Reporter: US-009507513-2384996, Same Reporter: US-009507513-2384865, Same Reporter: US-009507513-2384878, Same Reporter: US-009507513-2384924, Same Reporter: US-009507513-2384638, Same Reporter: US-009507513-2384835, Same Reporter: US-009507513-2384766, Same Reporter: US-009507513-2384721, Same Reporter: US-009507513-2384631, Same Reporter: US-009507513-2384628, Same Reporter: US-009507513-2384729, Same Reporter: US-009507513-2384817, Same Reporter: US-009507513-2384821, Same Reporter: US-009507513-2384624, Same Reporter: US-009507513-2384831, Same Reporter: US-009507513-2384930, Same Reporter: US-009507513-2384968, Same Reporter: US-009507513-2384649, Same Reporter: US-009507513-2384687, and Same Reporter: US-009507513-2385072
STERILE DILUENT